Shima M - Search Results

1

New assays for monitoring haemophilia treatment.

Shima M, Matsumoto T, Ogiwara K. Shima M, et al. Haemophilia. 2008 Jul;14 Suppl 3:83-92. doi: 10.1111/j.1365-2516.2008.01737.x. Haemophilia. 2008. PMID: 18510527 Review.

2

Clinical evaluation of recombinant human factor VIII (BAY w 6240) in the treatment of hemophilia A.

Fukui H, Yoshioka A, Shima M, Tanaka I, Koshihara K, Fukutake K, Fujimaki M. Fukui H, et al. Among authors: shima m. Int J Hematol. 1991 Oct;54(5):419-27. Int J Hematol. 1991. PMID: 1756252 Clinical Trial.

3

Thrombelastgram as a hemostatic monitor during recombinant factor VIIa treatment in hemophilia A patients with inhibitor to factor VIII.

Yoshioka A, Nishio K, Shima M. Yoshioka A, et al. Among authors: shima m. Haemostasis. 1996;26 Suppl 1:139-42. doi: 10.1159/000217256. Haemostasis. 1996. PMID: 8904189

4

Safety and efficacy of a new recombinant FVIII formulated with sucrose (rFVIII-FS) in patients with haemophilia A: a long-term, multicentre clinical study in Japan.

Yoshioka A, Shima M, Fukutake K, Takamatsu J, Shirahata A; Coganate FS Study Group. Yoshioka A, et al. Among authors: shima m. Haemophilia. 2001 May;7(3):242-9. doi: 10.1046/j.1365-2516.2001.00511.x. Haemophilia. 2001. PMID: 11380627 Clinical Trial.

5

Immunological characterization of factor VIII autoantibodies in patients with acquired hemophilia A in the presence or absence of underlying disease.

Matsumoto T, Shima M, Fukuda K, Nogami K, Giddings JC, Murakami T, Tanaka I, Yoshioka A. Matsumoto T, et al. Among authors: shima m. Thromb Res. 2001 Dec 15;104(6):381-8. doi: 10.1016/s0049-3848(01)00385-1. Thromb Res. 2001. PMID: 11755947

6

The utility of activated partial thromboplastin time (aPTT) clot waveform analysis in the investigation of hemophilia A patients with very low levels of factor VIII activity (FVIII:C).

Shima M, Matsumoto T, Fukuda K, Kubota Y, Tanaka I, Nishiya K, Giles AR, Yoshioka A. Shima M, et al. Thromb Haemost. 2002 Mar;87(3):436-41. Thromb Haemost. 2002. PMID: 11916076

7

Management of haemophilia B inhibitor patients with anaphylactic reactions to FIX concentrates.

Shibata M, Shima M, Misu H, Okimoto Y, Giddings JC, Yoshioka A. Shibata M, et al. Among authors: shima m. Haemophilia. 2003 May;9(3):269-71. doi: 10.1046/j.1365-2516.2003.00772.x. Haemophilia. 2003. PMID: 12694516

8

Anticoagulant activity of M-LAO, L-amino acid oxidase purified from Agkistrodon halys blomhoffii, through selective inhibition of factor IX.

Sakurai Y, Shima M, Matsumoto T, Takatsuka H, Nishiya K, Kasuda S, Fujimura Y, Yoshioka A. Sakurai Y, et al. Among authors: shima m. Biochim Biophys Acta. 2003 Jun 26;1649(1):51-7. doi: 10.1016/s1570-9639(03)00157-2. Biochim Biophys Acta. 2003. PMID: 12818190

9

Understanding the hemostatic effects of recombinant factor VIIa by clot wave form analysis.

Shima M. Shima M. Semin Hematol. 2004 Jan;41(1 Suppl 1):125-31. doi: 10.1053/j.seminhematol.2003.11.021. Semin Hematol. 2004. PMID: 14872433 Review.

10

Effectiveness of factor VIII infusions in haemophilia A patients with high responding inhibitors.

Kasuda S, Tanaka I, Shima M, Matsumoto T, Sakurai Y, Nishiya K, Giles AR, Yoshioka A. Kasuda S, et al. Among authors: shima m. Haemophilia. 2004 Jul;10(4):341-6. doi: 10.1111/j.1365-2516.2004.00907.x. Haemophilia. 2004. PMID: 15230947

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

920 results

Search Page

Filters